A

Abeona Therapeutics

ABEO

4.80000
USD
-0.1
(-2.04%)
مفتوح الان
حجم التداول
1,277
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
282,843,012
أصول ذات صلة
B
BEAM
-1.310
(-4.14%)
30.330 USD
B
BLUE
-0.06000
(-5.26%)
1.08000 USD
C
CLLS
-0.11000
(-4.89%)
2.14000 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
F
FIXX
0
(0%)
0.000000 USD
K
KURA
-0.630
(-3.03%)
20.190 USD
M
MRKR
-0.17000
(-3.46%)
4.74000 USD
Q
QURE
-0.14500
(-1.89%)
7.51000 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
الأخبار المقالات

العنوان: Abeona Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.